These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 21150587

  • 1. Therapy of growth disorders.
    Ali O, Wyatt D.
    Curr Opin Endocrinol Diabetes Obes; 2011 Feb; 18(1):3-8. PubMed ID: 21150587
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM, Lindgren AC, Hagenäs L, Marcus C, Müller J, Blichfeldt S.
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone therapy.
    Dash RJ, Muralidharan R, Talwar V.
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [Abstract] [Full Text] [Related]

  • 4. [Growth hormone therapy].
    Krysiak R, Okopień B, Gdula-Dymek A.
    Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
    Sipilä I, Sintonen H, Hietanen H, Apajasalo M, Alanne S, Viita AM, Leinonen E.
    Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
    [Abstract] [Full Text] [Related]

  • 6. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [Abstract] [Full Text] [Related]

  • 7. Treatment approaches of growth failure.
    Rappaport R.
    Pediatr Endocrinol Rev; 2008 Dec; 6(2):257. PubMed ID: 19209477
    [No Abstract] [Full Text] [Related]

  • 8. Indications for growth hormone therapy in children.
    Kirk J.
    Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
    [Abstract] [Full Text] [Related]

  • 9. Treatment approaches for growth failure.
    Root AW.
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):51-2. PubMed ID: 18806726
    [No Abstract] [Full Text] [Related]

  • 10. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
    Rosenthal S, Cohen P, Clayton P, Backeljauw P, Bang P, Ten S.
    Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
    [No Abstract] [Full Text] [Related]

  • 11. Growth hormone therapy in adults and children.
    Levy RM.
    N Engl J Med; 2000 Feb 03; 342(5):359. PubMed ID: 10660404
    [No Abstract] [Full Text] [Related]

  • 12. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep 03; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 13. Treatment approaches for growth failure.
    Rosenbloom AL.
    Pediatr Endocrinol Rev; 2008 Sep 03; 6(1):48-50. PubMed ID: 18806725
    [No Abstract] [Full Text] [Related]

  • 14. [Recommendations for the clinical use of recombinant human growth hormone in children].
    Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association The Editorial Board, Chinese Journal of Pediatrics.
    Zhonghua Er Ke Za Zhi; 2013 Jun 03; 51(6):426-32. PubMed ID: 24120059
    [No Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug 03; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone therapy for short stature: is the benefit worth the burden?
    Allen DB.
    Pediatrics; 2006 Jul 03; 118(1):343-8. PubMed ID: 16818584
    [No Abstract] [Full Text] [Related]

  • 17. Advances in pediatric growth hormone therapy: IGF-I-based dosing.
    Pawlikowska-Haddal A, Cohen P.
    Indian Pediatr; 2006 Jul 03; 43(7):577-81. PubMed ID: 16891676
    [No Abstract] [Full Text] [Related]

  • 18. Growth-promoting hormone therapy in inflammatory bowel disease.
    Savage MO.
    J Pediatr Gastroenterol Nutr; 2010 Dec 03; 51 Suppl 3():S135-6. PubMed ID: 21088536
    [No Abstract] [Full Text] [Related]

  • 19. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.
    Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P, Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.
    J Pediatr; 2003 Oct 03; 143(4):415-21. PubMed ID: 14571209
    [No Abstract] [Full Text] [Related]

  • 20. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
    Ranke MB, Wollmann HA, Savage MO.
    J Pediatr Endocrinol Metab; 1999 Apr 03; 12 Suppl 1():259-66. PubMed ID: 10698590
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.